Methodological Considerations of registry-based cluster-randomized controlled trials in hemodialysis

血液透析中基于登记的整群随机对照试验的方法学考虑

• 批准号: 365451
• 负责人: Al-Jaishi Ahmed
• 金额: $ 7.65万
• 依托单位: McMaster University
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-10-01 至 2019-10-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=365451&lang=en
• 关键词: Administrative Data; Cluster Randomized Controlled Trials; Dialysis

Dialysis is a life-saving treatment for the 23,000 Canadians and two million individuals worldwide whose kidneys have failed. These patients have very high death rates and are 30 times more likely to die compared to the general population at the same age.

透析是一种拯救生命的治疗方法，适用于23，000名加拿大人和全球200万肾衰竭的人。这些患者的死亡率非常高，与同龄的普通人群相比，死亡的可能性高出30倍。